Gianluca Spitaleri Selected Research

Doxorubicin (Adriamycin)

1/2015

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluca Spitaleri Research Topics

Disease

29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 03/2004
16	Neoplasms (Cancer) 03/2018 - 05/2004
6	Disease Progression 01/2020 - 05/2007
4	Lung Neoplasms (Lung Cancer) 06/2021 - 04/2011
4	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2006
3	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 05/2007
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 01/2006
2	Thrombosis (Thrombus) 01/2020 - 01/2006
2	Adenocarcinoma 10/2018 - 09/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2015 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2014 - 12/2011
2	Pain (Aches) 01/2009 - 09/2007
1	Oncogene Addiction 10/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Pneumonia (Pneumonitis) 06/2021
1	Pulmonary Embolism 01/2020
1	COVID-19 01/2020
1	Anorexia 04/2014
1	Hypophosphatemia 04/2014
1	Asthenia 04/2014
1	Thymoma (Thymic Carcinoma) 01/2014
1	Lymphoma (Lymphomas) 12/2012
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 08/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2010
1	Venous Thromboembolism 10/2005
1	Squamous Cell Carcinoma of Head and Neck 05/2004

Drug/Important Bio-Agent (IBA)

9	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2011
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2007
6	Immune Checkpoint InhibitorsIBA 09/2023 - 04/2016
5	CrizotinibIBA 01/2023 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 09/2007
4	PlatinumIBA 01/2023 - 04/2011
3	Anaplastic Lymphoma KinaseIBA 10/2019 - 06/2015
3	VaccinesIBA 04/2016 - 09/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015 - 01/2009
3	Interleukin-2 (IL2)IBA 01/2015 - 11/2010
3	Gefitinib (Iressa)FDA Link 01/2009 - 05/2007
3	Hormones (Hormone)IBA 01/2009 - 05/2007
3	Androgen Antagonists (Antiandrogens)IBA 01/2009 - 05/2007
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2009 - 05/2007
2	Gemcitabine FDA Link 03/2018 - 04/2011
2	NivolumabIBA 11/2017 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 01/2014
2	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 01/2014
2	Fibronectins (Fibronectin)IBA 12/2011 - 11/2010
2	Immunoglobulin FragmentsIBA 12/2011 - 11/2010
2	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 05/2004
2	Analgesics (Analgesic Drugs)IBA 01/2009 - 09/2007
2	Fluorouracil (Carac)FDA LinkGeneric 01/2006 - 05/2004
1	Adenosine Monophosphate (AMP)IBA 09/2023
1	Thioredoxin-Disulfide ReductaseIBA 05/2022
1	pembrolizumabIBA 01/2022
1	ensartinibIBA 10/2019
1	5'-Nucleotidase (5' Nucleotidase)IBA 03/2018
1	ceritinibIBA 06/2015
1	EGF Family of ProteinsIBA 02/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	CytokinesIBA 01/2015
1	Drug CombinationsIBA 01/2015
1	Everolimus FDA Link 04/2014
1	Alanine Transaminase (SGPT)IBA 04/2014
1	Dacarbazine (DIC)FDA LinkGeneric 12/2011
1	asparagine-glycine-arginineIBA 04/2011
1	Pemetrexed (MTA)FDA Link 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2011
1	human CNGRC fusion protein tumor necrosis factor-alphaIBA 04/2011
1	L19-IL2 immunocytokineIBA 11/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2009
1	Cancer VaccinesIBA 09/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007
1	anilinoquinazolineIBA 05/2007
1	Prothrombin (Factor II)IBA 01/2006
1	factor V LeidenIBA 01/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2004
1	taxaneIBA 05/2004

Therapy/Procedure

8	Therapeutics 09/2023 - 12/2011
7	Drug Therapy (Chemotherapy) 01/2023 - 01/2006
5	Immunotherapy 05/2022 - 09/2007
3	Radiotherapy 01/2020 - 12/2012
3	Catheters 01/2020 - 10/2005
1	Lasers (Laser) 03/2018
1	Combination Drug Therapy (Combination Chemotherapy) 03/2018
1	Liver Transplantation 01/2009
1	Central Venous Catheters 01/2006
1	Intravenous Infusions 05/2004
1	Chemoprevention 03/2004